Metachronous lung cancer: indication and outcome

M. Chida, T. Hasumi, Yasushi Hoshikawa, Y. Matsumura, M. Sato, M. Handa, T. Kondo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Although lobectomy is the standard surgical treatment for primary lung cancer, it is unclear whether lobectomy will be benefit for patients with metachronous lung cancer. The purpose of this study is to evaluate the difference of benefit between lobectomy and limited resection at second lung resection. Forty-eight patients, who had already undergone lobectomy due to primary lung cancer, undergoing second lobectomy (n = 30) or limited resection (n = 18) for metachronous lung cancer were investigated. The over-all 5-year survival rate of second operation was 51.9%. Although there was no significant difference of 5-year survival rates between lobectomy and limited resection, 50.4% and 49.4%, respectively, lobectomy for T1N0 subset prolonged the survival compared to limited resection, 5-year survival rates, 69.6% and 31.7%, respectively. However, lobectomy resulted in more postoperative complications and less preservation of lung function. Lobectomy should be considered the surgical procedure of choice for patients with metachronous T1N0 lung cancer when lung function is preserved.

Original languageEnglish
Pages (from-to)41-44
Number of pages4
JournalKyobu geka. The Japanese journal of thoracic surgery
Volume55
Issue number1
Publication statusPublished - 01-01-2002

Fingerprint

Lung Neoplasms
Survival Rate
Lung
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Chida, M., Hasumi, T., Hoshikawa, Y., Matsumura, Y., Sato, M., Handa, M., & Kondo, T. (2002). Metachronous lung cancer: indication and outcome. Kyobu geka. The Japanese journal of thoracic surgery, 55(1), 41-44.
Chida, M. ; Hasumi, T. ; Hoshikawa, Yasushi ; Matsumura, Y. ; Sato, M. ; Handa, M. ; Kondo, T. / Metachronous lung cancer : indication and outcome. In: Kyobu geka. The Japanese journal of thoracic surgery. 2002 ; Vol. 55, No. 1. pp. 41-44.
@article{6e8c7d411e8c45d2b3498c873b1b3d3e,
title = "Metachronous lung cancer: indication and outcome",
abstract = "Although lobectomy is the standard surgical treatment for primary lung cancer, it is unclear whether lobectomy will be benefit for patients with metachronous lung cancer. The purpose of this study is to evaluate the difference of benefit between lobectomy and limited resection at second lung resection. Forty-eight patients, who had already undergone lobectomy due to primary lung cancer, undergoing second lobectomy (n = 30) or limited resection (n = 18) for metachronous lung cancer were investigated. The over-all 5-year survival rate of second operation was 51.9{\%}. Although there was no significant difference of 5-year survival rates between lobectomy and limited resection, 50.4{\%} and 49.4{\%}, respectively, lobectomy for T1N0 subset prolonged the survival compared to limited resection, 5-year survival rates, 69.6{\%} and 31.7{\%}, respectively. However, lobectomy resulted in more postoperative complications and less preservation of lung function. Lobectomy should be considered the surgical procedure of choice for patients with metachronous T1N0 lung cancer when lung function is preserved.",
author = "M. Chida and T. Hasumi and Yasushi Hoshikawa and Y. Matsumura and M. Sato and M. Handa and T. Kondo",
year = "2002",
month = "1",
day = "1",
language = "English",
volume = "55",
pages = "41--44",
journal = "Japanese Journal of Thoracic Surgery",
issn = "0021-5252",
publisher = "Nankodo Co., Ltd.",
number = "1",

}

Chida, M, Hasumi, T, Hoshikawa, Y, Matsumura, Y, Sato, M, Handa, M & Kondo, T 2002, 'Metachronous lung cancer: indication and outcome', Kyobu geka. The Japanese journal of thoracic surgery, vol. 55, no. 1, pp. 41-44.

Metachronous lung cancer : indication and outcome. / Chida, M.; Hasumi, T.; Hoshikawa, Yasushi; Matsumura, Y.; Sato, M.; Handa, M.; Kondo, T.

In: Kyobu geka. The Japanese journal of thoracic surgery, Vol. 55, No. 1, 01.01.2002, p. 41-44.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Metachronous lung cancer

T2 - indication and outcome

AU - Chida, M.

AU - Hasumi, T.

AU - Hoshikawa, Yasushi

AU - Matsumura, Y.

AU - Sato, M.

AU - Handa, M.

AU - Kondo, T.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Although lobectomy is the standard surgical treatment for primary lung cancer, it is unclear whether lobectomy will be benefit for patients with metachronous lung cancer. The purpose of this study is to evaluate the difference of benefit between lobectomy and limited resection at second lung resection. Forty-eight patients, who had already undergone lobectomy due to primary lung cancer, undergoing second lobectomy (n = 30) or limited resection (n = 18) for metachronous lung cancer were investigated. The over-all 5-year survival rate of second operation was 51.9%. Although there was no significant difference of 5-year survival rates between lobectomy and limited resection, 50.4% and 49.4%, respectively, lobectomy for T1N0 subset prolonged the survival compared to limited resection, 5-year survival rates, 69.6% and 31.7%, respectively. However, lobectomy resulted in more postoperative complications and less preservation of lung function. Lobectomy should be considered the surgical procedure of choice for patients with metachronous T1N0 lung cancer when lung function is preserved.

AB - Although lobectomy is the standard surgical treatment for primary lung cancer, it is unclear whether lobectomy will be benefit for patients with metachronous lung cancer. The purpose of this study is to evaluate the difference of benefit between lobectomy and limited resection at second lung resection. Forty-eight patients, who had already undergone lobectomy due to primary lung cancer, undergoing second lobectomy (n = 30) or limited resection (n = 18) for metachronous lung cancer were investigated. The over-all 5-year survival rate of second operation was 51.9%. Although there was no significant difference of 5-year survival rates between lobectomy and limited resection, 50.4% and 49.4%, respectively, lobectomy for T1N0 subset prolonged the survival compared to limited resection, 5-year survival rates, 69.6% and 31.7%, respectively. However, lobectomy resulted in more postoperative complications and less preservation of lung function. Lobectomy should be considered the surgical procedure of choice for patients with metachronous T1N0 lung cancer when lung function is preserved.

UR - http://www.scopus.com/inward/record.url?scp=0036370828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036370828&partnerID=8YFLogxK

M3 - Article

C2 - 11797408

AN - SCOPUS:0036370828

VL - 55

SP - 41

EP - 44

JO - Japanese Journal of Thoracic Surgery

JF - Japanese Journal of Thoracic Surgery

SN - 0021-5252

IS - 1

ER -

Chida M, Hasumi T, Hoshikawa Y, Matsumura Y, Sato M, Handa M et al. Metachronous lung cancer: indication and outcome. Kyobu geka. The Japanese journal of thoracic surgery. 2002 Jan 1;55(1):41-44.